91 related articles for article (PubMed ID: 18030615)
1. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
[TBL] [Abstract][Full Text] [Related]
2. Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.
Koop EA; van Laar T; van Wichen DF; de Weger RA; Wall Ev; van Diest PJ
BMC Cancer; 2009 Jun; 9():175. PubMed ID: 19505343
[TBL] [Abstract][Full Text] [Related]
3. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.
Berg A; Fasmer KE; Mauland KK; Ytre-Hauge S; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Woie K; Bjørge L; Bjørnerud A; Salvesen HB; Werner HM; Krakstad C; Haldorsen IS
Oncotarget; 2016 Oct; 7(43):69844-69856. PubMed ID: 27634881
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines.
Fanale D; Bazan V; Caruso S; Castiglia M; Bronte G; Rolfo C; Cicero G; Russo A
Biomed Res Int; 2013; 2013():746858. PubMed ID: 24171172
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks.
Mirzaei S; Ranjbar B; Tackallou SH; Aref AR
Pathol Res Pract; 2023 Aug; 248():154676. PubMed ID: 37454494
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes.
Badowska-Kozakiewicz AM; Sobol M; Patera J
Arch Med Sci; 2017 Oct; 13(6):1303-1314. PubMed ID: 29181060
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cell Dysfunction in Premenopausal
Haran S; Chindera K; Sabry M; Wilkinson N; Arora R; Zubiak A; Bartlett TE; Evans I; Jones A; Reisel D; Herzog C; Alkasalias T; Newman M; Kim J; Rådestad AF; Gemzell-Danielsson K; Rosenthal AN; Dubeau L; Lowdell MW; Widschwendter M
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539519
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and breast cancer: prognostic and therapeutic implications.
Lundgren K; Holm C; Landberg G
Cell Mol Life Sci; 2007 Dec; 64(24):3233-47. PubMed ID: 17957335
[TBL] [Abstract][Full Text] [Related]
9. AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers.
Guirouilh-Barbat J; Wilhelm T; Lopez BS
Oncotarget; 2010 Dec; 1(8):691-699. PubMed ID: 21321378
[TBL] [Abstract][Full Text] [Related]
10. Role of HIF-1α in Ameloblastoma: A Systematic Review.
Jain A; Sharma P; Sivakumar N; Devi P; Gupta S; Chandra S
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3136-3145. PubMed ID: 37974737
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Hypoxia, oxidative stress, and endocrine cancers.
Duvillié B; Jockers R
Front Endocrinol (Lausanne); 2023; 14():1268268. PubMed ID: 37908751
[No Abstract] [Full Text] [Related]
12. Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer.
Ben Ali F; Qmichou Z; Oukabli M; Dakka N; Bakri Y; Eddouks M; Ameziane El Hassani R
Explor Target Antitumor Ther; 2024; 5(2):384-399. PubMed ID: 38745772
[TBL] [Abstract][Full Text] [Related]
13. Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence.
Murali R; Balasubramaniam V; Srinivas S; Sundaram S; Venkatraman G; Warrier S; Dharmarajan A; Gandhirajan RK
Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110218
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Predictive Biomarkers in Familial Breast Cancer.
Deb S; Chakrabarti A; Fox SB
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831687
[TBL] [Abstract][Full Text] [Related]
15. Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG.
Ding YC; Adamson AW; Bakhtiari M; Patrick C; Park J; Laitman Y; Weitzel JN; Bafna V; Friedman E; Neuhausen SL
Eur J Hum Genet; 2023 Feb; 31(2):216-222. PubMed ID: 36434258
[TBL] [Abstract][Full Text] [Related]
16. UCA1 Overexpression Promotes Hypoxic Breast Cancer Cell Proliferation and Inhibits Apoptosis via HIF-1
Choudhry H
J Oncol; 2021; 2021():5512156. PubMed ID: 34054950
[TBL] [Abstract][Full Text] [Related]
17. Plasma Metabolome Signature Indicative of
Penkert J; Märtens A; Seifert M; Auber B; Derlin K; Hille-Betz U; Hörmann P; Klopp N; Prokein J; Schlicker L; Wacker F; Wallaschek H; Schlegelberger B; Hiller K; Ripperger T; Illig T
Front Oncol; 2021; 11():627217. PubMed ID: 33898308
[TBL] [Abstract][Full Text] [Related]
18. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
19. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
[TBL] [Abstract][Full Text] [Related]
20. Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation.
Hong R; Zhang W; Xia X; Zhang K; Wang Y; Wu M; Fan J; Li J; Xia W; Xu F; Chen J; Wang S; Zhan Q
Mol Oncol; 2019 Apr; 13(4):959-977. PubMed ID: 30714292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
